Ares Capital is a business development company (BDC) that provides capital to middle-market companies with $10 million to ...

Blue Owl Capital's recent earnings highlight a 75% year-over-year AUM increase and a 25% dividend raise. Read why I upgrade ...

Main Street Capital's rising non-accruals indicate deteriorating fundamentals amidst high valuations. Read why profit-taking ...

Collectively, prognosticators following Ares stock were anticipating the company would earn more than $785 million in revenue and post a bottom-line profit of $0.58 per share. In the earnings release, ...

Collectively, prognosticators following Ares stock were anticipating the company ... investing market for acquisition finance and growth capital opportunities." DeVeer won't be quoted too often ...

In a robust display of market confidence, Solar Capital Ltd (NASDAQ:SLRC) stock has reached a 52-week high, touching $17.14. With a market capitalization of $934.52 million and an attractive P/E ratio ...

Given the risks around tariffs and inflation, plus significant back-to-back yearly gains for stocks, the "market’s multiple expansion tank is out of gas and stocks will require earnings growth to move ...

Ares Capital's (NASDAQ: ARCC) stock has increased only about 40% during the past 10 years. If we include its reinvested dividends, it's delivered a stunning total return of nearly 260%.

JMP Securities reaffirmed their confidence in Arch Capital's (NASDAQ:ACGL) potential in the property and casualty (P&C) insurance market, maintaining both the stock's price target at $125.00 and a ...

RBC Capital analyst Brian Abrahams maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report) yesterday and set a price target of ...

Palantir produced $2.8 billion in revenues in 2024, far and above BBAI’s $165 million. While that’s not a dealbreaker, ...